{"id":343106,"date":"2025-08-22T11:22:26","date_gmt":"2025-08-22T11:22:26","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-compass-pathways\/"},"modified":"2025-08-22T11:22:26","modified_gmt":"2025-08-22T11:22:26","slug":"how-to-buy-compass-pathways","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/","title":{"rendered":"COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; COMPASS Pathways plc (CMPS) Hisse Senedi Yat\u0131r\u0131m\u0131"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-343106","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r - COMPASS Pathways plc (CMPS) Hisse Senedi Yat\u0131r\u0131m\u0131","h1_source":{"label":"H1","type":"text","formatted_value":"COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r - COMPASS Pathways plc (CMPS) Hisse Senedi Yat\u0131r\u0131m\u0131"},"description":"COMPASS Pathways plc (CMPS) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin, psikedelik t\u0131ptaki b\u00fcy\u00fcme potansiyelini analiz edin ve 2025-2030 i\u00e7in bilin\u00e7li yat\u0131r\u0131m kararlar\u0131 verin.","description_source":{"label":"Description","type":"textarea","formatted_value":"COMPASS Pathways plc (CMPS) hisselerinin nas\u0131l al\u0131naca\u011f\u0131n\u0131 \u00f6\u011frenin, psikedelik t\u0131ptaki b\u00fcy\u00fcme potansiyelini analiz edin ve 2025-2030 i\u00e7in bilin\u00e7li yat\u0131r\u0131m kararlar\u0131 verin."},"intro":"Psikedelik t\u0131p devrimi burada ve COMPASS Pathways bu \u00e7\u0131\u011f\u0131r a\u00e7an d\u00f6n\u00fc\u015f\u00fcm\u00fcn \u00f6n saflar\u0131nda yer al\u0131yor. Depresyon tedavisini sonsuza dek de\u011fi\u015ftirebilecek bir \u015firkete yat\u0131r\u0131m yapmay\u0131 hayal edin\u2014bu bilim kurgu de\u011fil, \u015fu anda ger\u00e7ekle\u015fiyor. Ruh sa\u011fl\u0131\u011f\u0131 fark\u0131ndal\u0131\u011f\u0131n\u0131n her zamankinden y\u00fcksek oldu\u011fu ve geleneksel tedavilerin s\u0131kl\u0131kla yetersiz kald\u0131\u011f\u0131 bir d\u00f6nemde, COMPASS t\u0131bbi tarihin bir par\u00e7as\u0131 olma ve ayn\u0131 zamanda servetinizi b\u00fcy\u00fctme potansiyeli sunan benzersiz bir f\u0131rsat sunuyor.","intro_source":{"label":"Intro","type":"text","formatted_value":"Psikedelik t\u0131p devrimi burada ve COMPASS Pathways bu \u00e7\u0131\u011f\u0131r a\u00e7an d\u00f6n\u00fc\u015f\u00fcm\u00fcn \u00f6n saflar\u0131nda yer al\u0131yor. Depresyon tedavisini sonsuza dek de\u011fi\u015ftirebilecek bir \u015firkete yat\u0131r\u0131m yapmay\u0131 hayal edin\u2014bu bilim kurgu de\u011fil, \u015fu anda ger\u00e7ekle\u015fiyor. Ruh sa\u011fl\u0131\u011f\u0131 fark\u0131ndal\u0131\u011f\u0131n\u0131n her zamankinden y\u00fcksek oldu\u011fu ve geleneksel tedavilerin s\u0131kl\u0131kla yetersiz kald\u0131\u011f\u0131 bir d\u00f6nemde, COMPASS t\u0131bbi tarihin bir par\u00e7as\u0131 olma ve ayn\u0131 zamanda servetinizi b\u00fcy\u00fctme potansiyeli sunan benzersiz bir f\u0131rsat sunuyor."},"body_html":"<h2>Zihinsel Sa\u011fl\u0131k Yat\u0131r\u0131mlar\u0131n\u0131n Gelece\u011fini A\u00e7mak<\/h2> <p>Psikedelik t\u0131p devrimi burada ve COMPASS Pathways bu \u00e7\u0131\u011f\u0131r a\u00e7an d\u00f6n\u00fc\u015f\u00fcm\u00fcn \u00f6n saflar\u0131nda yer al\u0131yor. Depresyon tedavisini sonsuza dek de\u011fi\u015ftirebilecek bir \u015firkete yat\u0131r\u0131m yapmay\u0131 hayal edin\u2014bu bilim kurgu de\u011fil, \u015fu anda ger\u00e7ekle\u015fiyor. Ruh sa\u011fl\u0131\u011f\u0131 fark\u0131ndal\u0131\u011f\u0131n\u0131n her zamankinden y\u00fcksek oldu\u011fu ve geleneksel tedavilerin s\u0131kl\u0131kla yetersiz kald\u0131\u011f\u0131 bir d\u00f6nemde, COMPASS t\u0131bbi tarihin bir par\u00e7as\u0131 olma ve ayn\u0131 zamanda servetinizi b\u00fcy\u00fctme potansiyeli sunan benzersiz bir f\u0131rsat sunuyor.<\/p> [cta_green text=\"Ticarete Ba\u015fla\"]<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Hisse Performans\u0131<\/h2> <p>22 A\u011fustos 2025 itibar\u0131yla, COMPASS Pathways (CMPS) <strong>hisse ba\u015f\u0131na 4,09 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014bu, bu volatil ancak umut vadeden sekt\u00f6re giri\u015f yapmay\u0131 d\u00fc\u015f\u00fcnen yat\u0131r\u0131mc\u0131lar i\u00e7in kritik bir d\u00f6neme\u00e7tir. Hisse senedi olduk\u00e7a dalgal\u0131 bir seyir izledi, bu da onu hem heyecan verici hem de sinir bozucu bir yat\u0131r\u0131m f\u0131rsat\u0131 haline getiriyor.<\/p> <p><strong>Takviminize not edin: 30 Ekim 2025<\/strong>\u2014COMPASS'\u0131n bir sonraki kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih. Tarihsel olarak, bu a\u00e7\u0131klamalar b\u00fcy\u00fck fiyat hareketlerine yol a\u00e7t\u0131. 31 Temmuz kazan\u00e7lar\u0131ndan sonra ne oldu\u011funu hat\u0131rlay\u0131n m\u0131? Hisse senedi, yat\u0131r\u0131mc\u0131lar Faz 3 deneme sonu\u00e7lar\u0131 ve finansal g\u00fcncellemeleri sindirirken dramatik \u015fekilde dalgaland\u0131.<\/p> <h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3> <table> <thead> <tr><th>Tarih<\/th><th>Olay<\/th><th>Fiyat Hareketi<\/th><th>\u00d6nemli \u00c7\u0131kar\u0131m<\/th><\/tr> <\/thead> <tbody> <tr><td>31 Temmuz 2025<\/td><td>2. \u00c7eyrek Kazan\u00e7lar\u0131 + Faz 3 Sonu\u00e7lar\u0131<\/td><td>\u00b1%15-20 volatilite<\/td><td>Klinik ba\u015far\u0131ya kar\u0131\u015f\u0131k tepki<\/td><\/tr> <tr><td>Nisan 2025<\/td><td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td><td>%8 haftal\u0131k kazan\u00e7<\/td><td>\u0130stikrarl\u0131 operasyonel ilerleme<\/td><\/tr> <tr><td>Ocak 2025<\/td><td>Y\u0131l Sonu Sonu\u00e7lar\u0131<\/td><td>%12 d\u00fc\u015f\u00fc\u015f sonras\u0131 a\u00e7\u0131klama<\/td><td>Muhafazakar rehberlik yat\u0131r\u0131mc\u0131lar\u0131 korkuttu<\/td><\/tr> <\/tbody> <\/table> <p>Model, olumlu haberlerin genellikle hisseyi y\u00fckseltti\u011fini g\u00f6sterirken, biyoteknoloji sekt\u00f6r\u00fcn\u00fcn do\u011fas\u0131 gere\u011fi volatilitesi nedeniyle iyi haberlerin bile kar realizasyonuna yol a\u00e7abilece\u011fini ortaya koyuyor. Ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar bu tarihlere kartal gibi dikkat eder.<\/p> <h2>\ud83c\udfaf Ad\u0131m Ad\u0131m: CMPS Fiyat Hareketlerini Ustaca Y\u00f6netmek<\/h2> <ul> <li><strong>Ad\u0131m 1: Tetikleyici Tarihleri Belirleyin<\/strong> - Kazan\u00e7 tarihlerini (sonraki: 30 Ekim) ve FDA toplant\u0131 takvimlerini i\u015faretleyin<\/li> <li><strong>Ad\u0131m 2: Fiyat Uyar\u0131lar\u0131 Kurun<\/strong> - Destek seviyesi olarak 3,50 $ ve diren\u00e7 seviyesi olarak 5,00 $ kullan\u0131n<\/li> <li><strong>Ad\u0131m 3: Hacim Analizi<\/strong> - Ola\u011fand\u0131\u015f\u0131 i\u015flem hacmi i\u00e7in izleyin (2M+ hisse kurumsal ilgiyi g\u00f6sterir)<\/li> <li><strong>Ad\u0131m 4: Haber Takibi<\/strong> - D\u00fczenleyici g\u00fcncellemeleri bir dedektif gibi takip edin<\/li> <li><strong>Ad\u0131m 5: Teknik G\u00f6stergeler<\/strong> - RSI 30\u2019un alt\u0131nda a\u015f\u0131r\u0131 sat\u0131m, 70\u2019in \u00fczerinde a\u015f\u0131r\u0131 al\u0131m sinyali verir<\/li> <\/ul> <h2>\ud83d\udcca Alt\u0131 Ayl\u0131k Fiyat Yolculu\u011fu: Umutsuzluktan Umuda<\/h2> <p>\u015eubat 2025\u2019ten A\u011fustos 2025\u2019e kadar CMPS\u2019nin \u00e7\u0131lg\u0131n yolculu\u011funu inceleyelim:<\/p> <ul> <li><strong>\u015eubat 2025<\/strong>: Yakla\u015f\u0131k 3,80 $ - Deneme sonu\u00e7lar\u0131 \u00f6ncesi istikrarl\u0131 ama gergin<\/li> <li><strong>Mart-Nisan<\/strong>: 4,50 $\u2019a t\u0131rman\u0131\u015f - Faz 3 verileri hakk\u0131nda erken iyimserlik<\/li> <li><strong>May\u0131s<\/strong>: 3,20 $\u2019a d\u00fczeltme - Kar realizasyonu ve sekt\u00f6r rotasyonu<\/li> <li><strong>23 Haziran<\/strong>: Dipte 2,35 $ - Maksimum korku d\u00f6nemi<\/li> <li><strong>Temmuz<\/strong>: 4,00 $+\u2019a toparlanma - Faz 3 ba\u015far\u0131s\u0131 a\u00e7\u0131kland\u0131<\/li> <li><strong>A\u011fustos<\/strong>: 4,09 $\u2019da konsolidasyon - Yeni denge bulunuyor<\/li> <\/ul> <p>Bu, Haziran diplerinden itibaren <strong>%74\u2019l\u00fck bir toparlanma<\/strong> anlam\u0131na gelir\u2014biyoteknoloji yat\u0131r\u0131mlar\u0131nda hem a\u015f\u0131r\u0131 risk hem de potansiyel \u00f6d\u00fcl\u00fc g\u00f6steren klasik bir \"V \u015feklinde\" toparlanma.<\/p> <h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2> <ul> <li><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: 6-8 $ aral\u0131\u011f\u0131 (%46-95 y\u00fckseli\u015f)<br> <em>Neden?<\/em>: FDA g\u00f6r\u00fc\u015fmeleri ilerliyor ve COMP006 deneme kayd\u0131 tamamlan\u0131yor<\/li> <li><strong>2026 Projeksiyonu<\/strong>: 12-15 $ (%193-266 b\u00fcy\u00fcme)<br> <em>Tetikleyici<\/em>: COMP006 sonu\u00e7lar\u0131 2026 ikinci yar\u0131s\u0131nda bekleniyor<\/li> <li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 25-30 $ (%511-633 potansiyel)<br> <em>Itici G\u00fc\u00e7<\/em>: Olas\u0131 FDA onay\u0131 ve ticari lansman<\/li> <li><strong>2030 Vizyonu<\/strong>: 40-50+ $ (%878-1122 getiri)<br> <em>Temel<\/em>: Pazar geni\u015flemesi ve olas\u0131 yeni endikasyonlar<\/li> <\/ul> <p><strong>Karar<\/strong>: Risk tolerans\u0131 y\u00fcksek yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Analist konsens\u00fcs\u00fc de ayn\u0131 fikirde\u2014ortalama fiyat hedefi <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/CMPS\/forecast\/\">MarketBeat<\/a> verilerine g\u00f6re 16,29 $ olup %298 y\u00fckseli\u015f potansiyeli sunuyor.<\/p> <h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Gitmeden \u00d6nce Bilin<\/h2> <ul> <li><strong>Y\u00fcksek Volatilite Riski<\/strong>: CMPS tek bir g\u00fcnde %20 dalgalanabilir. Kalp ilac\u0131 kullan\u0131yorsan\u0131z, bu hisse size uygun olmayabilir.<\/li> <li><strong>D\u00fczenleyici Belirsizlik<\/strong>: FDA yava\u015f ve \u00f6ng\u00f6r\u00fclemez hareket eder. MDMA ile ne oldu\u011funu hat\u0131rlay\u0131n m\u0131? Dan\u0131\u015fma komitesi oylamas\u0131 sekt\u00f6rde kaosa yol a\u00e7t\u0131.<\/li> <li><strong>Klinik Deneme Riski<\/strong>: COMP006 ba\u015far\u0131s\u0131z olabilir. Tarihsel olarak Faz 3 denemelerinin ba\u015far\u0131 oran\u0131 yakla\u015f\u0131k %60't\u0131r.<\/li> <li><strong>Hisse Seyrelme Tehlikesi<\/strong>: Biyoteknoloji \u015firketleri genellikle nakit toplamak i\u00e7in daha fazla hisse \u00e7\u0131kar\u0131r, bu da sahiplik oran\u0131n\u0131z\u0131 azaltabilir.<\/li> <li><strong>Piyasa Duyarl\u0131l\u0131\u011f\u0131<\/strong>: Psikedelik hisseler haber ak\u0131\u015f\u0131na ve sosyal medya trendlerine kar\u015f\u0131 \u00e7ok hassast\u0131r.<\/li> <\/ul> <h2>\ud83d\udfe2 Olumlu Sinyaller: Yat\u0131r\u0131mc\u0131lar\u0131n Heyecanlanma Nedenleri<\/h2> <ul> <li><strong>Faz 3 Ba\u015far\u0131s\u0131<\/strong>: \u015eirket, COMP005\u2019te istatistiksel olarak anlaml\u0131 sonu\u00e7lar elde etti\u2014klasik bir psikedelik i\u00e7in ilk olumlu Faz 3 verisi olarak <a href=\"https:\/\/ir.compasspathways.com\/News--Events-\/news\/news-details\/2025\/Compass-Pathways-Successfully-Achieves-Primary-Endpoint-in-First-Phase-3-Trial-Evaluating-COMP360-Psilocybin-for-Treatment-Resistant-Depression\/default.aspx\">\u015firket raporlar\u0131nda<\/a> bildirildi.<\/li> <li><strong>Devasa Pazar<\/strong>: Tedaviye diren\u00e7li depresyon d\u00fcnya \u00e7ap\u0131nda milyonlarca insan\u0131 etkiliyor ve s\u0131n\u0131rl\u0131 tedavi se\u00e7ene\u011fi var\u2014bu \u00e7ok milyar dolarl\u0131k bir f\u0131rsat anlam\u0131na geliyor.<\/li> <li><strong>D\u00fczenleyici Destek<\/strong>: FDA\u2019dan Al\u0131nan Breakthrough Therapy (At\u0131l\u0131m Tedavi) stat\u00fcs\u00fc, bu tedavinin ilerlemesine ciddi ilgi g\u00f6sterildi\u011fini ortaya koyuyor.<\/li> <li><strong>Analist \u0130yimserli\u011fi<\/strong>: Bir\u00e7ok firma 40 $+ fiyat hedefi belirlemi\u015f, uzun vadeli ba\u015far\u0131 konusunda g\u00fcveni g\u00f6steriyor.<\/li> <li><strong>Sekt\u00f6r Momentum<\/strong>: Psikedelik t\u0131p pazar\u0131, <a href=\"https:\/\/www.rootsanalysis.com\/reports\/global-psychedelic-therapeutics-market.html\">sekt\u00f6r analizine<\/a> g\u00f6re 2030\u2019a kadar 2,77 milyar dolardan 6,75 milyar dolara b\u00fcy\u00fcmesi bekleniyor.<\/li> <\/ul> <h2>\ud83d\udcf0 Son Haber Etkisi: Haziran 2025 D\u00f6n\u00fcm Noktas\u0131<\/h2> <p>2025\u2019in en b\u00fcy\u00fck haberi 23 Haziran\u2019da geldi; COMPASS, Faz 3 denemesinin birincil hedefini ba\u015far\u0131yla kar\u015f\u0131lad\u0131\u011f\u0131n\u0131 duyurdu. M\u00fckemmel klinik habere ra\u011fmen, hisse ba\u015flang\u0131\u00e7ta %36-46 d\u00fc\u015ft\u00fc \u00e7\u00fcnk\u00fc yat\u0131r\u0131mc\u0131lar daha iyi sonu\u00e7lar bekliyordu\u2014klasik \"dedikoduyu al, haberi sat\" durumu.<\/p> <p>Bu, uzun vadeli \u00f6nemi anlayanlar i\u00e7in m\u00fcthi\u015f bir al\u0131m f\u0131rsat\u0131 yaratt\u0131. Deneme, plaseboya k\u0131yasla depresyon skorlar\u0131nda 3,6 puanl\u0131k azalma g\u00f6sterdi\u2014istatistiksel olarak anlaml\u0131 ve klinik olarak \u00f6nemli. En \u00f6nemlisi, g\u00fcvenlik verileri temizdi ve yeni bir endi\u015fe yoktu.<\/p> <h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayanlar \u0130\u00e7in Bug\u00fcnk\u00fc \u0130\u015flem Plan\u0131<\/h2> <ol> <li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong> - Portf\u00f6y\u00fcn\u00fcz\u00fcn %5\u2019inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li> <li><strong>Dolar Maliyet Ortalamas\u0131<\/strong> - Zamanlama riskini azaltmak i\u00e7in toplu de\u011fil par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li> <li><strong>Stop-Loss Belirleyin<\/strong> - Giri\u015f noktas\u0131ndan %25 a\u015fa\u011f\u0131da zarar durdurma koyarak kendinizi koruyun<\/li> <li><strong>Esprili Ger\u00e7eklik Kontrol\u00fc<\/strong>: \"CMPS ile i\u015flem yapmak, ba\u011fl\u0131l\u0131k sorunu olan biriyle \u00e7\u0131kmak gibidir\u2014heyecan verici ama duygusal \u00e7alkant\u0131ya haz\u0131rl\u0131kl\u0131 olun. Belki mide ila\u00e7lar\u0131n\u0131z\u0131 yan\u0131n\u0131zda bulundurun!\"<\/li> <\/ol> <h2>\u2705 COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r - Ad\u0131m Ad\u0131m<\/h2> <table> <thead> <tr><th>Ad\u0131m<\/th><th>\u0130\u015flem<\/th><th>Neden \u00d6nemli<\/th><\/tr> <\/thead> <tbody> <tr><td>1<\/td><td>Bir Ticaret Platformu Se\u00e7in<\/td><td>NASDAQ listeleri ve kesirli hisse sunmas\u0131na dikkat edin<\/td><\/tr> <tr><td>2<\/td><td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td><td>Uygun belgelerle genellikle 1-2 i\u015f g\u00fcn\u00fc s\u00fcrer<\/td><\/tr> <tr><td>3<\/td><td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td><td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td><\/tr> <tr><td>4<\/td><td>\"CMPS\" Aramas\u0131 Yap\u0131n<\/td><td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td><\/tr> <tr><td>5<\/td><td>Sipari\u015f T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td><td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td><\/tr> <tr><td>6<\/td><td>\u0130nceleyin ve Onaylay\u0131n<\/td><td>Komisyon \u00fccretlerini kontrol edin\u2014%1\u2019in alt\u0131nda hedefleyin<\/td><\/tr> <tr><td>7<\/td><td>Pozisyonunuzu Takip Edin<\/td><td>\u00d6nemli seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td><\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option Neden Mant\u0131kl\u0131?<\/h2> <p>CMPS gibi hisselere ad\u0131m atmak isteyenler i\u00e7in Pocket Option, giri\u015f s\u00fcrecini kolayla\u015ft\u0131ran birka\u00e7 avantaj sunar:<\/p> <ul> <li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile pratik yapmaya ve \u00f6\u011frenmeye ba\u015flayabilirsiniz\u2014hatalar\u0131n maliyetli olabilece\u011fi volatil hisseler i\u00e7in kritik<\/li> <li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek belge KYC s\u00fcreci sayesinde f\u0131rsatlar ortaya \u00e7\u0131kt\u0131\u011f\u0131nda hemen i\u015flem yapmaya ba\u015flayabilirsiniz<\/li> <li><strong>\u00c7ekim Esnekli\u011fi<\/strong>: 100\u2019den fazla y\u00f6ntemle karlar\u0131n\u0131za kolayca eri\u015febilirsiniz<\/li> <\/ul> <p>Bu \u00f6zellikler, zamanlama ve h\u0131zl\u0131 karar vermenin ba\u015far\u0131y\u0131 belirledi\u011fi biyoteknoloji hisselerinde i\u015flem yapmak i\u00e7in \u00f6zellikle de\u011ferlidir.<\/p> <h2>\ud83c\udf0d 2025\u2019te COMPASS Pathways: Zihinsel Sa\u011fl\u0131k Devriminin \u00d6nc\u00fcs\u00fc<\/h2> <p>COMPASS Pathways sadece ba\u015fka bir biyoteknoloji \u015firketi de\u011fil\u2014zihinsel sa\u011fl\u0131k tedavi kitab\u0131n\u0131 yeniden yazmaya \u00e7al\u0131\u015f\u0131yorlar. COMP360 sentetik psilosibin tedavisi, tedaviye diren\u00e7li depresyon i\u00e7in geli\u015ftirilen en geli\u015fmi\u015f psikedelik terapiyi temsil ediyor.<\/p> <p>\u015eirket, yat\u0131r\u0131mc\u0131 ili\u015fkileri alan\u0131nda aktif bir varl\u0131k s\u00fcrd\u00fcr\u00fcyor; A\u011fustos 2025\u2019te Canaccord Genuity konferans\u0131nda yat\u0131r\u0131m toplulu\u011funu ilerlemeleri hakk\u0131nda bilgilendirdi. Yakla\u015f\u0131k 400 milyon $ piyasa de\u011feri ile psikedelik t\u0131p alan\u0131nda saf bir yat\u0131r\u0131m f\u0131rsat\u0131 olarak konumlan\u0131yor\u2014ya muazzam ba\u015far\u0131ya ula\u015facaklar ya da denerken ba\u015far\u0131s\u0131z olacaklar.<\/p> <h3>\u0130lgin\u00e7 Bilgi:<\/h3> <p>2025\u2019te COMPASS, klasik bir psikedelik i\u00e7in olumlu Faz 3 etkinlik verisi raporlayan ilk \u015firket oldu\u2014t\u0131bbi tarihe ge\u00e7erek ve <a href=\"https:\/\/www.rootsanalysis.com\/reports\/global-psychedelic-therapeutics-market.html\">pazar ara\u015ft\u0131rmas\u0131na<\/a> g\u00f6re 2035\u2019e kadar 12 milyar dolarl\u0131k bir pazar a\u00e7ma potansiyeli ta\u015f\u0131yor. Sadece i\u015f y\u00fcr\u00fctm\u00fcyorlar; terap\u00f6tik bir devrime liderlik ediyorlar.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>Zihinsel Sa\u011fl\u0131k Yat\u0131r\u0131mlar\u0131n\u0131n Gelece\u011fini A\u00e7mak<\/h2>\n<p>Psikedelik t\u0131p devrimi burada ve COMPASS Pathways bu \u00e7\u0131\u011f\u0131r a\u00e7an d\u00f6n\u00fc\u015f\u00fcm\u00fcn \u00f6n saflar\u0131nda yer al\u0131yor. Depresyon tedavisini sonsuza dek de\u011fi\u015ftirebilecek bir \u015firkete yat\u0131r\u0131m yapmay\u0131 hayal edin\u2014bu bilim kurgu de\u011fil, \u015fu anda ger\u00e7ekle\u015fiyor. Ruh sa\u011fl\u0131\u011f\u0131 fark\u0131ndal\u0131\u011f\u0131n\u0131n her zamankinden y\u00fcksek oldu\u011fu ve geleneksel tedavilerin s\u0131kl\u0131kla yetersiz kald\u0131\u011f\u0131 bir d\u00f6nemde, COMPASS t\u0131bbi tarihin bir par\u00e7as\u0131 olma ve ayn\u0131 zamanda servetinizi b\u00fcy\u00fctme potansiyeli sunan benzersiz bir f\u0131rsat sunuyor.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/tr\/register\/\" class=\"po-cta-green\">Ticarete Ba\u015fla\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udcc8 G\u00fcncel Piyasa Konumu ve Hisse Performans\u0131<\/h2>\n<p>22 A\u011fustos 2025 itibar\u0131yla, COMPASS Pathways (CMPS) <strong>hisse ba\u015f\u0131na 4,09 $<\/strong> seviyesinde i\u015flem g\u00f6r\u00fcyor\u2014bu, bu volatil ancak umut vadeden sekt\u00f6re giri\u015f yapmay\u0131 d\u00fc\u015f\u00fcnen yat\u0131r\u0131mc\u0131lar i\u00e7in kritik bir d\u00f6neme\u00e7tir. Hisse senedi olduk\u00e7a dalgal\u0131 bir seyir izledi, bu da onu hem heyecan verici hem de sinir bozucu bir yat\u0131r\u0131m f\u0131rsat\u0131 haline getiriyor.<\/p>\n<p><strong>Takviminize not edin: 30 Ekim 2025<\/strong>\u2014COMPASS&#8217;\u0131n bir sonraki kazan\u00e7 raporunu yay\u0131nlayaca\u011f\u0131 tarih. Tarihsel olarak, bu a\u00e7\u0131klamalar b\u00fcy\u00fck fiyat hareketlerine yol a\u00e7t\u0131. 31 Temmuz kazan\u00e7lar\u0131ndan sonra ne oldu\u011funu hat\u0131rlay\u0131n m\u0131? Hisse senedi, yat\u0131r\u0131mc\u0131lar Faz 3 deneme sonu\u00e7lar\u0131 ve finansal g\u00fcncellemeleri sindirirken dramatik \u015fekilde dalgaland\u0131.<\/p>\n<h3>Tarihsel Kazan\u00e7 Etkisi Analizi<\/h3>\n<table>\n<thead>\n<tr>\n<th>Tarih<\/th>\n<th>Olay<\/th>\n<th>Fiyat Hareketi<\/th>\n<th>\u00d6nemli \u00c7\u0131kar\u0131m<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>31 Temmuz 2025<\/td>\n<td>2. \u00c7eyrek Kazan\u00e7lar\u0131 + Faz 3 Sonu\u00e7lar\u0131<\/td>\n<td>\u00b1%15-20 volatilite<\/td>\n<td>Klinik ba\u015far\u0131ya kar\u0131\u015f\u0131k tepki<\/td>\n<\/tr>\n<tr>\n<td>Nisan 2025<\/td>\n<td>1. \u00c7eyrek Kazan\u00e7lar\u0131<\/td>\n<td>%8 haftal\u0131k kazan\u00e7<\/td>\n<td>\u0130stikrarl\u0131 operasyonel ilerleme<\/td>\n<\/tr>\n<tr>\n<td>Ocak 2025<\/td>\n<td>Y\u0131l Sonu Sonu\u00e7lar\u0131<\/td>\n<td>%12 d\u00fc\u015f\u00fc\u015f sonras\u0131 a\u00e7\u0131klama<\/td>\n<td>Muhafazakar rehberlik yat\u0131r\u0131mc\u0131lar\u0131 korkuttu<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Model, olumlu haberlerin genellikle hisseyi y\u00fckseltti\u011fini g\u00f6sterirken, biyoteknoloji sekt\u00f6r\u00fcn\u00fcn do\u011fas\u0131 gere\u011fi volatilitesi nedeniyle iyi haberlerin bile kar realizasyonuna yol a\u00e7abilece\u011fini ortaya koyuyor. Ak\u0131ll\u0131 yat\u0131r\u0131mc\u0131lar bu tarihlere kartal gibi dikkat eder.<\/p>\n<h2>\ud83c\udfaf Ad\u0131m Ad\u0131m: CMPS Fiyat Hareketlerini Ustaca Y\u00f6netmek<\/h2>\n<ul>\n<li><strong>Ad\u0131m 1: Tetikleyici Tarihleri Belirleyin<\/strong> &#8211; Kazan\u00e7 tarihlerini (sonraki: 30 Ekim) ve FDA toplant\u0131 takvimlerini i\u015faretleyin<\/li>\n<li><strong>Ad\u0131m 2: Fiyat Uyar\u0131lar\u0131 Kurun<\/strong> &#8211; Destek seviyesi olarak 3,50 $ ve diren\u00e7 seviyesi olarak 5,00 $ kullan\u0131n<\/li>\n<li><strong>Ad\u0131m 3: Hacim Analizi<\/strong> &#8211; Ola\u011fand\u0131\u015f\u0131 i\u015flem hacmi i\u00e7in izleyin (2M+ hisse kurumsal ilgiyi g\u00f6sterir)<\/li>\n<li><strong>Ad\u0131m 4: Haber Takibi<\/strong> &#8211; D\u00fczenleyici g\u00fcncellemeleri bir dedektif gibi takip edin<\/li>\n<li><strong>Ad\u0131m 5: Teknik G\u00f6stergeler<\/strong> &#8211; RSI 30\u2019un alt\u0131nda a\u015f\u0131r\u0131 sat\u0131m, 70\u2019in \u00fczerinde a\u015f\u0131r\u0131 al\u0131m sinyali verir<\/li>\n<\/ul>\n<h2>\ud83d\udcca Alt\u0131 Ayl\u0131k Fiyat Yolculu\u011fu: Umutsuzluktan Umuda<\/h2>\n<p>\u015eubat 2025\u2019ten A\u011fustos 2025\u2019e kadar CMPS\u2019nin \u00e7\u0131lg\u0131n yolculu\u011funu inceleyelim:<\/p>\n<ul>\n<li><strong>\u015eubat 2025<\/strong>: Yakla\u015f\u0131k 3,80 $ &#8211; Deneme sonu\u00e7lar\u0131 \u00f6ncesi istikrarl\u0131 ama gergin<\/li>\n<li><strong>Mart-Nisan<\/strong>: 4,50 $\u2019a t\u0131rman\u0131\u015f &#8211; Faz 3 verileri hakk\u0131nda erken iyimserlik<\/li>\n<li><strong>May\u0131s<\/strong>: 3,20 $\u2019a d\u00fczeltme &#8211; Kar realizasyonu ve sekt\u00f6r rotasyonu<\/li>\n<li><strong>23 Haziran<\/strong>: Dipte 2,35 $ &#8211; Maksimum korku d\u00f6nemi<\/li>\n<li><strong>Temmuz<\/strong>: 4,00 $+\u2019a toparlanma &#8211; Faz 3 ba\u015far\u0131s\u0131 a\u00e7\u0131kland\u0131<\/li>\n<li><strong>A\u011fustos<\/strong>: 4,09 $\u2019da konsolidasyon &#8211; Yeni denge bulunuyor<\/li>\n<\/ul>\n<p>Bu, Haziran diplerinden itibaren <strong>%74\u2019l\u00fck bir toparlanma<\/strong> anlam\u0131na gelir\u2014biyoteknoloji yat\u0131r\u0131mlar\u0131nda hem a\u015f\u0131r\u0131 risk hem de potansiyel \u00f6d\u00fcl\u00fc g\u00f6steren klasik bir &#8220;V \u015feklinde&#8221; toparlanma.<\/p>\n<h2>\ud83d\udd2e Fiyat Tahmini: 2025-2030 G\u00f6r\u00fcn\u00fcm\u00fc<\/h2>\n<ul>\n<li><strong>2025 Y\u0131l Sonu Hedefi<\/strong>: 6-8 $ aral\u0131\u011f\u0131 (%46-95 y\u00fckseli\u015f)<br \/> <em>Neden?<\/em>: FDA g\u00f6r\u00fc\u015fmeleri ilerliyor ve COMP006 deneme kayd\u0131 tamamlan\u0131yor<\/li>\n<li><strong>2026 Projeksiyonu<\/strong>: 12-15 $ (%193-266 b\u00fcy\u00fcme)<br \/> <em>Tetikleyici<\/em>: COMP006 sonu\u00e7lar\u0131 2026 ikinci yar\u0131s\u0131nda bekleniyor<\/li>\n<li><strong>2028 G\u00f6r\u00fcn\u00fcm\u00fc<\/strong>: 25-30 $ (%511-633 potansiyel)<br \/> <em>Itici G\u00fc\u00e7<\/em>: Olas\u0131 FDA onay\u0131 ve ticari lansman<\/li>\n<li><strong>2030 Vizyonu<\/strong>: 40-50+ $ (%878-1122 getiri)<br \/> <em>Temel<\/em>: Pazar geni\u015flemesi ve olas\u0131 yeni endikasyonlar<\/li>\n<\/ul>\n<p><strong>Karar<\/strong>: Risk tolerans\u0131 y\u00fcksek yat\u0131r\u0131mc\u0131lar i\u00e7in G\u00dc\u00c7L\u00dc ALIM. Analist konsens\u00fcs\u00fc de ayn\u0131 fikirde\u2014ortalama fiyat hedefi <a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/CMPS\/forecast\/\">MarketBeat<\/a> verilerine g\u00f6re 16,29 $ olup %298 y\u00fckseli\u015f potansiyeli sunuyor.<\/p>\n<h2>\u26a0\ufe0f Risk De\u011ferlendirmesi: Gitmeden \u00d6nce Bilin<\/h2>\n<ul>\n<li><strong>Y\u00fcksek Volatilite Riski<\/strong>: CMPS tek bir g\u00fcnde %20 dalgalanabilir. Kalp ilac\u0131 kullan\u0131yorsan\u0131z, bu hisse size uygun olmayabilir.<\/li>\n<li><strong>D\u00fczenleyici Belirsizlik<\/strong>: FDA yava\u015f ve \u00f6ng\u00f6r\u00fclemez hareket eder. MDMA ile ne oldu\u011funu hat\u0131rlay\u0131n m\u0131? Dan\u0131\u015fma komitesi oylamas\u0131 sekt\u00f6rde kaosa yol a\u00e7t\u0131.<\/li>\n<li><strong>Klinik Deneme Riski<\/strong>: COMP006 ba\u015far\u0131s\u0131z olabilir. Tarihsel olarak Faz 3 denemelerinin ba\u015far\u0131 oran\u0131 yakla\u015f\u0131k %60&#8217;t\u0131r.<\/li>\n<li><strong>Hisse Seyrelme Tehlikesi<\/strong>: Biyoteknoloji \u015firketleri genellikle nakit toplamak i\u00e7in daha fazla hisse \u00e7\u0131kar\u0131r, bu da sahiplik oran\u0131n\u0131z\u0131 azaltabilir.<\/li>\n<li><strong>Piyasa Duyarl\u0131l\u0131\u011f\u0131<\/strong>: Psikedelik hisseler haber ak\u0131\u015f\u0131na ve sosyal medya trendlerine kar\u015f\u0131 \u00e7ok hassast\u0131r.<\/li>\n<\/ul>\n<h2>\ud83d\udfe2 Olumlu Sinyaller: Yat\u0131r\u0131mc\u0131lar\u0131n Heyecanlanma Nedenleri<\/h2>\n<ul>\n<li><strong>Faz 3 Ba\u015far\u0131s\u0131<\/strong>: \u015eirket, COMP005\u2019te istatistiksel olarak anlaml\u0131 sonu\u00e7lar elde etti\u2014klasik bir psikedelik i\u00e7in ilk olumlu Faz 3 verisi olarak <a href=\"https:\/\/ir.compasspathways.com\/News--Events-\/news\/news-details\/2025\/Compass-Pathways-Successfully-Achieves-Primary-Endpoint-in-First-Phase-3-Trial-Evaluating-COMP360-Psilocybin-for-Treatment-Resistant-Depression\/default.aspx\">\u015firket raporlar\u0131nda<\/a> bildirildi.<\/li>\n<li><strong>Devasa Pazar<\/strong>: Tedaviye diren\u00e7li depresyon d\u00fcnya \u00e7ap\u0131nda milyonlarca insan\u0131 etkiliyor ve s\u0131n\u0131rl\u0131 tedavi se\u00e7ene\u011fi var\u2014bu \u00e7ok milyar dolarl\u0131k bir f\u0131rsat anlam\u0131na geliyor.<\/li>\n<li><strong>D\u00fczenleyici Destek<\/strong>: FDA\u2019dan Al\u0131nan Breakthrough Therapy (At\u0131l\u0131m Tedavi) stat\u00fcs\u00fc, bu tedavinin ilerlemesine ciddi ilgi g\u00f6sterildi\u011fini ortaya koyuyor.<\/li>\n<li><strong>Analist \u0130yimserli\u011fi<\/strong>: Bir\u00e7ok firma 40 $+ fiyat hedefi belirlemi\u015f, uzun vadeli ba\u015far\u0131 konusunda g\u00fcveni g\u00f6steriyor.<\/li>\n<li><strong>Sekt\u00f6r Momentum<\/strong>: Psikedelik t\u0131p pazar\u0131, <a href=\"https:\/\/www.rootsanalysis.com\/reports\/global-psychedelic-therapeutics-market.html\">sekt\u00f6r analizine<\/a> g\u00f6re 2030\u2019a kadar 2,77 milyar dolardan 6,75 milyar dolara b\u00fcy\u00fcmesi bekleniyor.<\/li>\n<\/ul>\n<h2>\ud83d\udcf0 Son Haber Etkisi: Haziran 2025 D\u00f6n\u00fcm Noktas\u0131<\/h2>\n<p>2025\u2019in en b\u00fcy\u00fck haberi 23 Haziran\u2019da geldi; COMPASS, Faz 3 denemesinin birincil hedefini ba\u015far\u0131yla kar\u015f\u0131lad\u0131\u011f\u0131n\u0131 duyurdu. M\u00fckemmel klinik habere ra\u011fmen, hisse ba\u015flang\u0131\u00e7ta %36-46 d\u00fc\u015ft\u00fc \u00e7\u00fcnk\u00fc yat\u0131r\u0131mc\u0131lar daha iyi sonu\u00e7lar bekliyordu\u2014klasik &#8220;dedikoduyu al, haberi sat&#8221; durumu.<\/p>\n<p>Bu, uzun vadeli \u00f6nemi anlayanlar i\u00e7in m\u00fcthi\u015f bir al\u0131m f\u0131rsat\u0131 yaratt\u0131. Deneme, plaseboya k\u0131yasla depresyon skorlar\u0131nda 3,6 puanl\u0131k azalma g\u00f6sterdi\u2014istatistiksel olarak anlaml\u0131 ve klinik olarak \u00f6nemli. En \u00f6nemlisi, g\u00fcvenlik verileri temizdi ve yeni bir endi\u015fe yoktu.<\/p>\n<h2>\ud83d\udee1\ufe0f Yeni Ba\u015flayanlar \u0130\u00e7in Bug\u00fcnk\u00fc \u0130\u015flem Plan\u0131<\/h2>\n<ol>\n<li><strong>K\u00fc\u00e7\u00fck Ba\u015flay\u0131n<\/strong> &#8211; Portf\u00f6y\u00fcn\u00fcz\u00fcn %5\u2019inden fazlas\u0131n\u0131 y\u00fcksek riskli biyoteknoloji hisselerine ay\u0131rmay\u0131n<\/li>\n<li><strong>Dolar Maliyet Ortalamas\u0131<\/strong> &#8211; Zamanlama riskini azaltmak i\u00e7in toplu de\u011fil par\u00e7a par\u00e7a sat\u0131n al\u0131n<\/li>\n<li><strong>Stop-Loss Belirleyin<\/strong> &#8211; Giri\u015f noktas\u0131ndan %25 a\u015fa\u011f\u0131da zarar durdurma koyarak kendinizi koruyun<\/li>\n<li><strong>Esprili Ger\u00e7eklik Kontrol\u00fc<\/strong>: &#8220;CMPS ile i\u015flem yapmak, ba\u011fl\u0131l\u0131k sorunu olan biriyle \u00e7\u0131kmak gibidir\u2014heyecan verici ama duygusal \u00e7alkant\u0131ya haz\u0131rl\u0131kl\u0131 olun. Belki mide ila\u00e7lar\u0131n\u0131z\u0131 yan\u0131n\u0131zda bulundurun!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; Ad\u0131m Ad\u0131m<\/h2>\n<table>\n<thead>\n<tr>\n<th>Ad\u0131m<\/th>\n<th>\u0130\u015flem<\/th>\n<th>Neden \u00d6nemli<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Bir Ticaret Platformu Se\u00e7in<\/td>\n<td>NASDAQ listeleri ve kesirli hisse sunmas\u0131na dikkat edin<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Hesap Do\u011frulamas\u0131n\u0131 Tamamlay\u0131n<\/td>\n<td>Uygun belgelerle genellikle 1-2 i\u015f g\u00fcn\u00fc s\u00fcrer<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>Hesab\u0131n\u0131z\u0131 Fonlay\u0131n<\/td>\n<td>Kaybetmeyi g\u00f6ze alabilece\u011finiz bir miktarla ba\u015flay\u0131n<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>&#8220;CMPS&#8221; Aramas\u0131 Yap\u0131n<\/td>\n<td>\u015eirket ad\u0131 de\u011fil, sembol\u00fc kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Sipari\u015f T\u00fcr\u00fcn\u00fc Se\u00e7in<\/td>\n<td>Giri\u015f fiyat\u0131n\u0131z\u0131 kontrol etmek i\u00e7in limit emirleri kullan\u0131n<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>\u0130nceleyin ve Onaylay\u0131n<\/td>\n<td>Komisyon \u00fccretlerini kontrol edin\u2014%1\u2019in alt\u0131nda hedefleyin<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Pozisyonunuzu Takip Edin<\/td>\n<td>\u00d6nemli seviyeler i\u00e7in fiyat uyar\u0131lar\u0131 kurun<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 Yeni Yat\u0131r\u0131mc\u0131lar \u0130\u00e7in Pocket Option Neden Mant\u0131kl\u0131?<\/h2>\n<p>CMPS gibi hisselere ad\u0131m atmak isteyenler i\u00e7in Pocket Option, giri\u015f s\u00fcrecini kolayla\u015ft\u0131ran birka\u00e7 avantaj sunar:<\/p>\n<ul>\n<li><strong>Minimum Para Yat\u0131rma<\/strong>: Sadece 5 $ ile pratik yapmaya ve \u00f6\u011frenmeye ba\u015flayabilirsiniz\u2014hatalar\u0131n maliyetli olabilece\u011fi volatil hisseler i\u00e7in kritik<\/li>\n<li><strong>H\u0131zl\u0131 Do\u011frulama<\/strong>: Tek belge KYC s\u00fcreci sayesinde f\u0131rsatlar ortaya \u00e7\u0131kt\u0131\u011f\u0131nda hemen i\u015flem yapmaya ba\u015flayabilirsiniz<\/li>\n<li><strong>\u00c7ekim Esnekli\u011fi<\/strong>: 100\u2019den fazla y\u00f6ntemle karlar\u0131n\u0131za kolayca eri\u015febilirsiniz<\/li>\n<\/ul>\n<p>Bu \u00f6zellikler, zamanlama ve h\u0131zl\u0131 karar vermenin ba\u015far\u0131y\u0131 belirledi\u011fi biyoteknoloji hisselerinde i\u015flem yapmak i\u00e7in \u00f6zellikle de\u011ferlidir.<\/p>\n<h2>\ud83c\udf0d 2025\u2019te COMPASS Pathways: Zihinsel Sa\u011fl\u0131k Devriminin \u00d6nc\u00fcs\u00fc<\/h2>\n<p>COMPASS Pathways sadece ba\u015fka bir biyoteknoloji \u015firketi de\u011fil\u2014zihinsel sa\u011fl\u0131k tedavi kitab\u0131n\u0131 yeniden yazmaya \u00e7al\u0131\u015f\u0131yorlar. COMP360 sentetik psilosibin tedavisi, tedaviye diren\u00e7li depresyon i\u00e7in geli\u015ftirilen en geli\u015fmi\u015f psikedelik terapiyi temsil ediyor.<\/p>\n<p>\u015eirket, yat\u0131r\u0131mc\u0131 ili\u015fkileri alan\u0131nda aktif bir varl\u0131k s\u00fcrd\u00fcr\u00fcyor; A\u011fustos 2025\u2019te Canaccord Genuity konferans\u0131nda yat\u0131r\u0131m toplulu\u011funu ilerlemeleri hakk\u0131nda bilgilendirdi. Yakla\u015f\u0131k 400 milyon $ piyasa de\u011feri ile psikedelik t\u0131p alan\u0131nda saf bir yat\u0131r\u0131m f\u0131rsat\u0131 olarak konumlan\u0131yor\u2014ya muazzam ba\u015far\u0131ya ula\u015facaklar ya da denerken ba\u015far\u0131s\u0131z olacaklar.<\/p>\n<h3>\u0130lgin\u00e7 Bilgi:<\/h3>\n<p>2025\u2019te COMPASS, klasik bir psikedelik i\u00e7in olumlu Faz 3 etkinlik verisi raporlayan ilk \u015firket oldu\u2014t\u0131bbi tarihe ge\u00e7erek ve <a href=\"https:\/\/www.rootsanalysis.com\/reports\/global-psychedelic-therapeutics-market.html\">pazar ara\u015ft\u0131rmas\u0131na<\/a> g\u00f6re 2035\u2019e kadar 12 milyar dolarl\u0131k bir pazar a\u00e7ma potansiyeli ta\u015f\u0131yor. Sadece i\u015f y\u00fcr\u00fctm\u00fcyorlar; terap\u00f6tik bir devrime liderlik ediyorlar.<\/p>\n"},"faq":[{"question":"COMPASS Pathways hisseleri nas\u0131l al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"CMPS\" sembol\u00fc ile arama yap\u0131n, limit emirleri kullanarak sipari\u015f verin ve pozisyonunuzu takip edin."},{"question":"COMPASS Pathways hisselerinin riskleri nelerdir?","answer":"Y\u00fcksek volatilite, d\u00fczenleyici belirsizlik, klinik deneme riski, hisse seyrelmesi ve piyasa duyarl\u0131l\u0131\u011f\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"COMPASS Pathways hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 6-8 $, 2026\u2019da 12-15 $, 2028\u2019de 25-30 $ ve 2030\u2019da 40-50+ $ aral\u0131\u011f\u0131nda fiyat hedefleri \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama s\u00fcreci ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi sunarak giri\u015f s\u00fcrecini kolayla\u015ft\u0131r\u0131r."},{"question":"COMPASS Pathways neden \u00f6nemli bir yat\u0131r\u0131m f\u0131rsat\u0131d\u0131r?","answer":"Tedaviye diren\u00e7li depresyon i\u00e7in ilk olumlu Faz 3 psikedelik verisini sunmas\u0131, b\u00fcy\u00fck pazar potansiyeli ve FDA\u2019dan al\u0131nan destek nedeniyle \u00f6nemli bir yat\u0131r\u0131m f\u0131rsat\u0131d\u0131r."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"COMPASS Pathways hisseleri nas\u0131l al\u0131n\u0131r?","answer":"Bir ticaret platformu se\u00e7in, hesap do\u011frulamas\u0131n\u0131 tamamlay\u0131n, hesab\u0131n\u0131z\u0131 fonlay\u0131n, \"CMPS\" sembol\u00fc ile arama yap\u0131n, limit emirleri kullanarak sipari\u015f verin ve pozisyonunuzu takip edin."},{"question":"COMPASS Pathways hisselerinin riskleri nelerdir?","answer":"Y\u00fcksek volatilite, d\u00fczenleyici belirsizlik, klinik deneme riski, hisse seyrelmesi ve piyasa duyarl\u0131l\u0131\u011f\u0131 ba\u015fl\u0131ca risklerdir."},{"question":"COMPASS Pathways hisseleri i\u00e7in fiyat tahmini nedir?","answer":"2025 sonunda 6-8 $, 2026\u2019da 12-15 $, 2028\u2019de 25-30 $ ve 2030\u2019da 40-50+ $ aral\u0131\u011f\u0131nda fiyat hedefleri \u00f6ng\u00f6r\u00fclmektedir."},{"question":"Pocket Option yeni yat\u0131r\u0131mc\u0131lar i\u00e7in neden uygundur?","answer":"D\u00fc\u015f\u00fck minimum depozito, h\u0131zl\u0131 do\u011frulama s\u00fcreci ve \u00e7ok say\u0131da para \u00e7ekme y\u00f6ntemi sunarak giri\u015f s\u00fcrecini kolayla\u015ft\u0131r\u0131r."},{"question":"COMPASS Pathways neden \u00f6nemli bir yat\u0131r\u0131m f\u0131rsat\u0131d\u0131r?","answer":"Tedaviye diren\u00e7li depresyon i\u00e7in ilk olumlu Faz 3 psikedelik verisini sunmas\u0131, b\u00fcy\u00fck pazar potansiyeli ve FDA\u2019dan al\u0131nan destek nedeniyle \u00f6nemli bir yat\u0131r\u0131m f\u0131rsat\u0131d\u0131r."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r - COMPASS Pathways plc (CMPS) Hisse Senedi Yat\u0131r\u0131m\u0131<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/\" \/>\n<meta property=\"og:locale\" content=\"tr_TR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r - COMPASS Pathways plc (CMPS) Hisse Senedi Yat\u0131r\u0131m\u0131\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-22T11:22:26+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Yazan:\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; COMPASS Pathways plc (CMPS) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"datePublished\":\"2025-08-22T11:22:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/\"},\"wordCount\":21,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/\",\"name\":\"COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r - COMPASS Pathways plc (CMPS) Hisse Senedi Yat\u0131r\u0131m\u0131\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"datePublished\":\"2025-08-22T11:22:26+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#breadcrumb\"},\"inLanguage\":\"tr\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/tr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; COMPASS Pathways plc (CMPS) Hisse Senedi Yat\u0131r\u0131m\u0131\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"tr\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"tr\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r - COMPASS Pathways plc (CMPS) Hisse Senedi Yat\u0131r\u0131m\u0131","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/","og_locale":"tr_TR","og_type":"article","og_title":"COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r - COMPASS Pathways plc (CMPS) Hisse Senedi Yat\u0131r\u0131m\u0131","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-22T11:22:26+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Yazan:":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; COMPASS Pathways plc (CMPS) Hisse Senedi Yat\u0131r\u0131m\u0131","datePublished":"2025-08-22T11:22:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/"},"wordCount":21,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"tr","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/","url":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/","name":"COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r - COMPASS Pathways plc (CMPS) Hisse Senedi Yat\u0131r\u0131m\u0131","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","datePublished":"2025-08-22T11:22:26+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#breadcrumb"},"inLanguage":"tr","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/"]}]},{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/tr\/news-events\/signal\/how-to-buy-compass-pathways\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/tr\/"},{"@type":"ListItem","position":2,"name":"COMPASS Pathways plc (CMPS) Hisseleri Nas\u0131l Al\u0131n\u0131r &#8211; COMPASS Pathways plc (CMPS) Hisse Senedi Yat\u0131r\u0131m\u0131"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/tr\/#website","url":"https:\/\/pocketoption.com\/blog\/tr\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/tr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"tr"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/tr\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"tr","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/tr\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"tr_TR","wpml_translations":{"vt_VT":{"locale":"vt_VT","id":343102,"slug":"how-to-buy-compass-pathways","post_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu COMPASS Pathways plc (CMPS) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu COMPASS Pathways plc (CMPS)","href":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-compass-pathways\/"},"pt_AA":{"locale":"pt_AA","id":343103,"slug":"how-to-buy-compass-pathways","post_title":"Como comprar a\u00e7\u00f5es da COMPASS Pathways plc (CMPS) - Investimento em a\u00e7\u00f5es da COMPASS Pathways plc (CMPS)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-compass-pathways\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/343106","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/comments?post=343106"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/posts\/343106\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media\/334036"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/media?parent=343106"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/categories?post=343106"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/tr\/wp-json\/wp\/v2\/tags?post=343106"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}